The FDA has approved a new drug, Vyleesi, to treat hypoactive sexual desire disorder (HSDD) in women who haven’t yet gone through menopause. Vyleesi is only the second drug that’s been approved for the treatment of HSDD. The first was Addyi, which was approved in 2015.
The FDA has approved Slynd, a new version of the mini-pill that will bring much-needed flexibility to mini-pill users.
It’s Pride month! Yes, that means lots of fun events and general joie de vivre, but it’s about so much more than that. This year, consider doing the following to celebrate Pride (and don’t worry, you can still paint rainbows on your face and go get drunk, just do these things first).
We’ve rounded up our 10 favorite articles about sexual health and birth control from the past month to make it really easy for you to get the facts on the things that could affect your health.
We’ve rounded up our 10 favorite articles about sexual health and birth control from the past month to make it really easy for you to get the facts on the things that could affect your health.